Scientific Advice - Protocol Assistance

Peter Embley appointed as
Chief Regulatory Officer.

Missing image

Pete joins Arriello to lead it’s Regulatory Affairs team.

A focus on building up further expertise with new Principal Consultants, and our Clinical Regulatory Strategy and solutions.

Pete comes with over 24 years of experience working across the Pharmaceutical, CRO and Consulting Industries.

Grounded in UK and European regulatory activities, and in particular, developing and executing strategies for generic and early-stage development programs, his responsibilities have included, but not limited to; Agency Scientific Advice, feasibility of accelerated tools such as EMA-PRIME, MHRA-ILAP, CMC, PIP, Market-Access and MAA due-diligence.

More recently, Pete has supported US IND/EU CTA and Chinese IND submissions, leading a team for the development and execution of Early (& Post-Trial) Access Programs.

A keen advocate for professional regulatory development, Pete is a Fellow of the regulatory association (TOPRA), and a Module Leader on the TOPRA Regulatory Affairs MSc. course.  Pete is also a regular lecturer at the University of Limerick.

Pete will report to Arriello’s COO Anna Lukyanova.

Latest news.

We are pleased to announce our sponsorship of an event for CMOs in Co. Cork, Ireland, held by PDA Ireland Chapter.
Sponsoring & Exhibiting at PDA Ireland Event for CMOs.
Monika Čičová, Arriello’s Quality & Compliance Specialist – Auditing and Quality Assurance, will be presenting at the Conforum: “Farmakovigilance aktuálně a přehledně” 2024 conference.
Third Party Audit Management Presentation at Conforum 2024.
Our experts will describe how integrating all functions into a comprehensive and holistic regulatory strategy is the key for optimizing regulatory frameworks.
Open Registration: New Webinar on Pharma Regulatory Strategy.